Accession Therapeutics
The Oxford company is developing novel immuno-oncology therapeutics combining high specificity and potency with the ability to counter tumour diversity.
Accession Therapeutics has raised €19M across 1 funding round from 3 investors, most recently a round in Nov 2022. Based in Oxford, UK; active in Healthtech. Data as of 28 Oct 2026.
Oxford, UKaccessiontherapeutics.com ↗
Total raised
€19M
€19,167,263
Funding rounds
1
Investors
3
distinct backers
Active since
2022-11
latest 2022-11
Funding by year
EUR raised per yearAccession Therapeutics — funding by year — interactive chart.
Data table
| Accession Therapeutics — funding by year | |
|---|---|
| 2022 | €19M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-11-28 | Other | €19M | Birk Venture,iGlobe Partners,Primavera Venture Partners | View deal → |
Related news
- £16.6m raised by cancer-fighting startup Accession Therapeuticsbusinesscloud.co.uk · 2022-11
Similar companies
same sector or countryGlobal coverage: FundingData